II. Definition
- Inflammation and secondary infection at skinfolds
III. Pathophysiology
- Friction between skin at folds
- Moisture increased and air flow decreased
- Inflammation and maceration results in epidermal erosions and other skin breakdown
- Conditions allow for secondary superinfection
IV. Risk Factors
-
Obesity
- Linear worsening in severity with increasing BMI > 30 kg/m2
- Diabetes Mellitus
- Immunocompromised state (especially HIV Infection)
- Incontinence of urine or stool (with occlusive barriers such as diapers)
- Immobility
- Hyperhidrosis
- Poor hygiene
- Hot and humid environments
V. Organisms
- Fungus
- Candidal Intertrigo or Candidiasis (most common)
- Presents with erythema, Scaling, satellite lesions and foul odor
- Dermatophytes
- See Tinea Pedis and Tinea Cruris
- Candidal Intertrigo or Candidiasis (most common)
- Bacteria
VI. Distribution
- Most common sites
- Groin
- Axillae
- Inframammary folds
- Interdigital toe web space
- Athletes, laborers with closed-toe or tight shoes
- Less common sites
- Antecubital or popliteal fossa
- Umbilicus
- Perineum
- Neck area in infacts
- Angular Cheilitis
VII. Symptoms
- Itching, burning, and redness in affected skin fold
- Foul odor may be present
VIII. Signs
- Starts with mild erythema
- Later, area may become eroded, macerated, fissured
IX. Labs
- Potassium Hydroxide (KOH) for fungal organisms
- Wood's Lamp Examination
- Pseudomonas fluoresces green
- Erythrasma (Corynebacterium) fluoresces coral-red
X. Differential Diagnosis
- Inflammatory conditions
- Contact Dermatitis (Irritant or allergic)
- Atopic Dermatitis
- Skin Infections
- Chronic skin disorders
- Skin manifestations of endocrine disorders
-
Skin Malignancy
- Bowen Disease (squamous cell cancer in situ)
- Paget Disease
XI. Management
-
General
- Eliminate skin friction
- Consider absorbent (e.g. gauze) or breathable barrier agents between overlapping skin
- Eliminate moisture in skin folds with drying agents
- Talcum powder
- Barrier ointment
- Petroleum Jelly (Petrolatum, Vaseline)
- Zinc Oxide
- Wear light, breathable, or absorbent clothing
- Eliminate skin friction
- Treat infection
- Space application 2-3 hours from topical drying or barrier agents
- Antifungals
- Consider initial empiric Antifungal therapy
- Perform additional testing (e.g. KOH Preparation) if fails to improve after initial therapy
- First-line: Topical Antifungals
- Imidazoles (e.g. Clotrimazole, Oxiconazole, Econazole) cover all fungus (including candida and dermatophytes)
- Nystatin covers only Cutaneous Candidiasis (but this is most common)
- Second-line: Broad-spectrum Topical Antifungals
- Third-line: Oral Antifungals
- Fluconazole (Diflucan) 100-200 mg daily for 7 days (adult dose)
- Itraconazole (Sporanox)
- Consider initial empiric Antifungal therapy
- Antibiotics for Streptococcus or Staphylococcus
- See Erythrasma
- See Tinea Pedis
- See Interdigital Intertrigo Secondary Infection
- Topical Mupirocin (Bactroban)
- Oral Antibiotics
- See Cellulitis
- Streptococcus or MSSA
- MRSA (consider if abscess present, poorly demarcated or refractory to MSSA Antibiotics)
- Add trimethoprim-sulfamethoxazole (e.g. Septra) to Dicloxacillin or Cephalexin OR
- Doxycycline OR
- Clindamycin (depending on MRSA sensitivity in community)
- Consider Antibiotic in combination with topical low dose Corticosteroids (e.g. 1% Hydrocortisone)
XII. Prevention
- Keep intertriginous areas clean and dry
- Change moist or soiled clothing multiple times daily
- Weight loss
- Avoid heat and humidity
- Wear open-toe shoes
- Apply skin Emollients and barrier agents frequently
XIII. References
- Habif (2004) Clinical Dermatology, p. 446-50
- Janniger (2005) Am Fam Physician 72(5):833-8 [PubMed]
- Kalra (2014) Am Fam Physician 89(7): 569-73 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
Definition (SCTSPA) | Dermatitis superficial en superficies cutáneas opuestas |
Definition (SNOMEDCT_US) | Superficial dermatitis on opposed skin surfaces |
Definition (MSH) | A superficial dermatitis occurring on skin surfaces in contact with each other, such as the axillae, neck creases, intergluteal fold, between the toes, etc. Obesity is a predisposing factor. The condition is caused by moisture and friction and is characterized by erythema, maceration, burning, and exudation. |
Concepts | Disease or Syndrome (T047) |
MSH | D007402 |
ICD10 | L30.4 |
SnomedCT | 156366001, 200947005, 58759008 |
English | Intertrigo, intertrigo, intertrigo (diagnosis), Intertrigo [Disease/Finding], Eczema intertrigo, Erythema intertrigo, Intertrigo (disorder), eczema; intertriginous, erythema; intertrigo, intertriginous; eczema, intertrigo; erythema |
Japanese | 間擦疹, カンサツシン |
Swedish | Intertrigo |
Czech | opruzení, intertrigo, Intertrigo |
Finnish | Intertrigo |
Russian | INTERTRIGO, OPRELOST', ИНТЕРТРИГО, ОПРЕЛОСТЬ |
German | Intertriginoeses Ekzem, Intertrigo |
Korean | 간찰성 홍반 |
Polish | Wyprzenie |
Hungarian | Intertrigo |
Norwegian | Intertrigo |
Dutch | eczeem; intertrigineus, erytheem; intertrigo, intertrigineus; eczeem, intertrigo; erytheem, Intertrigineus eczeem, intertrigo, Eczeem, intertrigineus, Intertrigo |
Spanish | intertrigo (trastorno), intertrigo eccematoso, intertrigo eczematoso, intertrigo eritematoso, intertrigo, Intertrigo |
French | Intertrigo |
Italian | Intertrigine |
Portuguese | Intertrigo |